Latest Market News

Cann Group Limited has launched a comprehensive suite of option offers aimed at raising incremental capital, subject to shareholder approval at a December 23 meeting. The prospectus outlines potential dilution and financial impacts as the company seeks to strengthen its balance sheet.

Cyclopharm Limited has secured regulatory approval for its Technegas lung imaging technology in Colombia, marking its presence in 67 countries worldwide. This milestone aligns strategically with the upcoming global nuclear medicine congress in Cartagena.

BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics for US$4.8 billion includes Dimerix’s US licensing agreement, promising significant milestone payments and royalties. This deal strengthens Dimerix’s position as it advances its Phase 3 kidney disease therapy.

IVE Group has agreed to acquire Australian creative agency Daily Press for up to $35 million, bolstering its digital, social, and performance marketing capabilities as part of its ‘Now to 2030’ growth strategy.

Invictus Energy has completed the Petroleum Production Sharing Agreement process for its Cabora Bassa Project, setting the stage for significant gas exploration and development in Zimbabwe.

Lendlease has struck a binding agreement to sell a significant stake in its Malaysian TRX retail and office assets, marking a key step in its FY26 capital recycling strategy aimed at reducing gearing and unlocking value.

Strata Minerals Limited has successfully completed the first tranche of its $1.175 million capital raising, issuing over 55 million shares to investors. The company now awaits shareholder approval to complete the remaining funding.

FlexiRoam has secured a strategic partnership with Generali Insurance Malaysia to deploy its AI-driven eSIM connectivity platform through WhatsApp, targeting the growing travel insurance market.

Aurizon has lodged a proposed ten-year Network Access Undertaking with the Queensland Competition Authority, aiming to secure long-term certainty and enhanced operational incentives for the Central Queensland Coal Network.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

Meteoric Resources has obtained the Preliminary Environmental Licence without restriction for its Caldeira Rare Earth Ionic Clay Project in Brazil, clearing a key regulatory hurdle and keeping the project on track for mid-2026 construction.